No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
WATT Energous
- 0.8100
- -0.0500-5.81%
Close Jul 24 16:00 ET
- 0.8353
- +0.0253+3.12%
Post 19:47 ET
5.30MMarket Cap-223P/E (TTM)
0.8846High0.7950Low42.66KVolume0.8672Open0.8600Pre Close35.88KTurnover0.66%Turnover RatioLossP/E (Static)6.54MShares5.600052wk High0.74P/B5.21MFloat Cap0.630052wk Low--Dividend TTM6.44MShs Float670.0000Historical High--Div YieldTTM10.42%Amplitude0.6300Historical Low0.8410Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Energous Receives Multiple Orders From Multinational Retailer for Grocery Distribution
Energous Announces New Partners to Accelerate Adoption of Over-The-Air Wireless Power Technology
Express News | Energous And DigiKey Partner For Distribution
Express News | Energous Announces Value-Added Distribution Partnership With Digikey
12 Industrials Stocks Moving In Thursday's Pre-Market Session
Energous Raised to Buy From Neutral by Ladenburg Thalmann
Comments
$Agilent Technologies(A.US$ $Aramark(ARMK.US$ $CAVA Group(CAVA.US$ $Salesforce(CRM.US$ $Delcath Systems(DCTH.US$ $DLocal(DLO.US$ $Design Therapeutics(DSGN.US$ $Gol Intelligent Airlines(GOL.US$ $Hawaiian Electric Industries(HE.US$ $Mercury Systems(MRCY.US$ $Pagaya Technologies(PGY.US$ $Rumble(RUM.US$ $Sea(SE.US$ $SoundHound AI(SOUN.US$ $Energous(WATT.US$ $Workday(WDAY.US$
2
1
1
$Energous(WATT.US$ Stay short sighted hit and run now too bad aren't my style!Come on call watt supporters trust them this round!
1
1
$Energous(WATT.US$ They have finally going into international market this time! Previous failure only make them stronger!![]()
![]()
![]()
![]()
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
mizmo : ticker SONN is ramping up for a squeeze right now after being passed by the FDA for cancer research drug